MedMira receives CE mark for its VYRA™ COVID-19 Antigen Test
Halifax, Nova Scotia, 14 October, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of the CE mark for its VYRA™...
MedMira receives CE mark for its VYRA™ COVID-19 Antigen Test
MedMira provides Progress Update
Latest announcement by the FDA
MedMira announces the appointment of Dr. Sam Ratnam as Director of Scientific & Regulatory Affairs
MedMira Receives US Trademark for its REVEALCOVID-19
Notification of upcoming updates